Premium
A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort
Author(s) -
Taffé Patrick,
May Margaret
Publication year - 2008
Publication title -
statistics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.996
H-Index - 183
eISSN - 1097-0258
pISSN - 0277-6715
DOI - 10.1002/sim.3294
Subject(s) - imputation (statistics) , human immunodeficiency virus (hiv) , cohort , computer science , medicine , statistics , econometrics , virology , missing data , mathematics
Abstract In studies of the natural history of HIV‐1 infection, the time scale of primary interest is the time since infection. Unfortunately, this time is very often unknown for HIV infection and using the follow‐up time instead of the time since infection is likely to provide biased results because of onset confounding. Laboratory markers such as the CD4 T‐cell count carry important information concerning disease progression and can be used to predict the unknown date of infection. Previous work on this topic has made use of only one CD4 measurement or based the imputation on incident patients only. However, because of considerable intrinsic variability in CD4 levels and because incident cases are different from prevalent cases, back calculation based on only one CD4 determination per person or on characteristics of the incident sub‐cohort may provide unreliable results. Therefore, we propose a methodology based on the repeated individual CD4 T‐cells marker measurements that use both incident and prevalent cases to impute the unknown date of infection. Our approach uses joint modelling of the time since infection, the CD4 time path and the drop‐out process. This methodology has been applied to estimate the CD4 slope and impute the unknown date of infection in HIV patients from the Swiss HIV Cohort Study. A procedure based on the comparison of different slope estimates is proposed to assess the goodness of fit of the imputation. Results of simulation studies indicated that the imputation procedure worked well, despite the intrinsic high volatility of the CD4 marker. Copyright © 2008 John Wiley & Sons, Ltd.